 |
Diabetic Nephropathy (DN)
An accurate marker is needed to enable early detection of DN and those diabetics with a propensity to develop the disease to help determine the appropriate therapeutic intervention.
Our Technologies
Early Detection of Propensity of Diabetics to Develop Kidney Disease
- Option for exclusive worldwide license
- Protein in urine found to detect propensity in diabetics to develop kidney disease ten years earlier than any other method
- Research based upon SELDI-Mass Spec proteomic profiling method
- Validation of data using MALDI-Mass Spec platform underway
- Patent application filed
Detection of Kidney Disease in Diabetics
- Option for exclusive worldwide license
- Three proteins differentially expressed in urine of diabetic patients
- SELDI-Mass Spec platform or point of care delivery system
- US provisional patent application filed
Market Size
Diabetic Nephropathy
- Approximately 170 million diabetics worldwide, 20 million in the US alone
- 160,000 people in the US with end-stage kidney disease due to diabetes are living on dialysis or with a kidney transplant
- Savings to Medicare for each patient who does not progress to dialysis is approximately $250,000
|
|
|
|
|
 |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
 |
Diabetic Nephropathy (DN) |
|
|
| |
|
|
| |
|
|
 |
|
